Leritrelvir shows high efficacy against SARS-CoV-2 protease mutations

By Frédéric Revah, PhD Frédéric Revah, PhDCEO, Généthon Here at Généthon, a nonprofit research organization, we have a history of accepting big challenges. At our

By ac­quir­ing Ec­co­gene’s GLP-1, As­traZeneca is bet­ting not just on the long-term po­ten­tial of the obe­si­ty drug mar­ket, but the val­ue of com­bin­ing the weight-loss